Clinical trial • Phase I • Neurology
Clinical trial in Stroke
Phase I trial for Stroke. 144 participants.
Overview
- Trial Therapeutic Area
- Neurology
- Trial Disease
- Stroke
- Trial Stage
- Phase I
- Drug Modality
- Cell therapy
Key dates
- Initial CTIS Submission Date
- 07-10-2024
- First CTIS Authorization Date
- 05-11-2024
Trial design
Phase I trial across 6 sites in France.
- Target Sample Size
- 144
Eligibility
Recruits 144 Vulnerable population selected; no details on consent or assent handling available in provided documents..
- Vulnerable Population
- Vulnerable population selected; no details on consent or assent handling available in provided documents.
Recruitment
- Planned Sample Size
- 144
- Recruitment Window Months
- 96
Geography
- Total Number Of Sites
- 6
- Total Number Of Participants
- 144
France
- Earliest CTIS Part Ii Submission Date
- 28-10-2024
- Latest Decision Or Authorization Date
- 20-03-2025
- Processing Time Days
- 143
- Number Of Sites
- 6
- Number Of Participants
- 144
Sites
- Site Name
- Hopitaux Universitaires Pitie Salpetriere
- Department Name
- Urgences Cérébro-Vasculaires
- Contact Person Name
- Charlotte ROSSO
- Contact Person Email
- charlotte.rosso@aphp.fr
- Site Name
- Centre Hospitalier Universitaire De Bordeaux
- Department Name
- Neurovasculaire
- Contact Person Name
- Igor SIBON
- Contact Person Email
- igor.sibon@chu-grenoble.fr
- Site Name
- CHU de Besançon
- Department Name
- Neurovasculaire
- Contact Person Name
- Louise BONNET
- Contact Person Email
- l1bonnet@chu-besancon.fr
- Site Name
- Centre Hospitalier Universitaire De Lille
- Department Name
- Neurologie Vasculaire
- Contact Person Name
- Lucie DELLA SCHIAVA
- Contact Person Email
- Lucie.DELLASCHIAVA@chu-lille.fr
- Site Name
- Centre Hospitalier Universitaire Grenoble Alpes
- Department Name
- Neurovasculaire
- Contact Person Name
- Olivier DETANTE
- Contact Person Email
- odetante@chu-grenoble.fr
- Site Name
- GHU St Anne Psychiatrie et Neurosciences
- Department Name
- Neurovasculaire
- Contact Person Name
- David CALVET
- Contact Person Email
- d.calvet@ghu-paris.fr
Sponsor
Primary sponsor
- Full Name
- Centre Hospitalier Universitaire Grenoble Alpes
- Organisation Type
- Hospital/Clinic/Other health care facility
- Country Of Registered Address
- France
Related trials
Other published trials that may interest you.